vimarsana.com

Page 23 - டோ ஜோன்ஸ் நிலைத்தன்மை குறியீடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |F Hoffmann-La Roche Ltd Announcements | F Hoffmann-La Roche Ltd: CHMP recommends EU approval of Roche s ENSPRYNG (satralizumab) for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD)

Investegate |F Hoffmann-La Roche Ltd Announcements | F Hoffmann-La Roche Ltd: CHMP recommends EU approval of Roche s ENSPRYNG (satralizumab) for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD)
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

F Hoffmann-La Roche Ltd: Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy

F Hoffmann-La Roche Ltd: Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy

Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Roche purchases shares in tender offer for GenMark Diagnostics, Inc

Share: Basel, 22 April 2021 - Roche ((SIX: RO, ROG, OTCQX:RHHBY) and GenMark Diagnostics, Inc. today announced that Roche s wholly owned subsidiary Geronimo Acquisition Corp. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) at a price of USD 24.05 per share in cash. The tender offer expired at 12:00 midnight, Eastern Time, at the end of the day on 21 April 2021 and was not extended. Roche has been advised by Citibank, N.A., the depositary for the tender offer, that a total of approximately 61,201,761 shares of GenMark s common stock were validly tendered and not validly withdrawn in the tender offer (excluding shares tendered by notice of guaranteed delivery for which certificates have not yet been received ), which represent approximately 82.89% of the total number of shares of GenMark s common stock outstanding.

Case study: Leonardo transforms its corporate governance with integrated thinking

Case study: Leonardo transforms its corporate governance with integrated thinking Posted 22 April, 2021 The IR Business Network’s Integrated Thinking & Strategy Group publishes its latest case study on integrated thinking in action from Leonardo. Leonardo is a leading aerospace, defence and security technology company. Headquartered in Italy, the organization has over 49,000 employees and a significant industrial presence in Italy, the United Kingdom, the United States and Poland. Integrated thinking has supported Leonardo in realizing the interconnectivity of financial and non-financial aspects of the business to improve sustainability. It has been key to developing Leonardo’s holistic understanding of its business and delivering on its purpose: to ‘Contribute to the world’s progress and safety by delivering meaningful and innovative technological solutions.’

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.